ESC 365
ESC 365
Sign in
Menu
Menu
Back
Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic
European Heart Journal - Cardiovascular Pharmacotherapy
4 October 2024
Organised by:
Read full article
ESC Journals
CARDIOVASCULAR PHARMACOLOGY
Contributors
Stefan Agewall
Author
Karolinska Institute Stockholm
,
Sweden
You may be interested in
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
Congress Presentation
Proximal thoracic aortopathy: what do the latest guidelines say? - focus on medical therapy